Loading...
NPI 1316159601 · East Syracuse, NY · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Olga Kligerman is a hematology & oncology physician provider located in East Syracuse, New York. This profile covers 62 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Olga Kligerman |
| Address | 5008 Brittonfield Pkwy |
| City | East Syracuse |
| State | NY |
| ZIP | 13057 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | May 7, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $841.9K |
| Medicaid | $1.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
62 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 8,800 | $40 | $378.5K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,890 | $40 | $109.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 660 | $90 | $61.9K |
| J0897 | Injection, denosumab, 1 mg | 2,460 | $20 | $46.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 35,250 | $1 | $35.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $100 | $29.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,060 | $10 | $18.4K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 300 | $60 | $16.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 250 | $60 | $14.7K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 60 | $170 | $10.6K |
Showing 1–10 of 62
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 62 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
62 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 38 | 60 | 9,900 | $40 | $505.5K |
| J1561 | 23 | 40 | 3,100 | $40 | $234.9K |
| J0897 | 273 | 490 | 2,820 | $20 | $84.4K |
| J3490 | 37 | 120 | 60 | $470 | $50.8K |
| J1439 | 49 | 90 | 39,750 | $1 | $42K |
| J0885 | 22 | 50 | 2,530 | $10 | $26.1K |
| 99214 | 1,802 | 30,450 | 90 | $100 | $19K |
| 96413 | 52 | 380 | 110 | $110 | $18.1K |
| 74177 | 886 | 1,350 | 110 | $100 | $14.8K |
| 99232 | 9,853 | 11,850 | 80 | $70 | $13.8K |
Showing 1–10 of 62
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | $50 | $1.7K |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 13,133 | 16,550 | 220 | $90 | $186.8K |
Other providers in the same ZIP code as Olga Kligerman, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Syracuse Endoscopy Associates, LLC | NY | Endoscopy Clinic/Center | $560.3K | $1.1M |
| K&a Radiologic Technology Services Inc | NY | Portable X-ray and/or Other Portable Diagnostic Imaging Supplier | $638.2K | $89.1K |
| Upstate Orthopedics Ambulatory Surgery Center LLC | NY | Ambulatory Surgical Clinic/Center | $402.5K | $83.6K |
| Benny Wong | NY | Hematology & Oncology Physician | $403.7K | $7.3K |
| Vinod Varki | NY | Hematology & Oncology Physician | $388.7K | $0 |
| Aref Agheli | NY | Hematology & Oncology Physician | $364.3K | $1.8K |
| Jeffrey Cizenski | NY | Dermatology Physician | $290.7K | $0 |
| Robert Sherman | NY | Orthopaedic Surgery Physician | $258.5K | $5K |
| Traian Anghel | NY | Clinical Cardiac Electrophysiology Physician | $256K | $190 |
| Hassan Shukri-mahmod | NY | Neurology Physician | $215.9K | $12.8K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.